pharmaceutical financing

 {Photo credit: Alan Levine via Flickr / CC BY}Vials of insulin. Diabetes medicines and health technologies, including lifesaving insulin, are available in only one in three of the world’s poorest countries.Photo credit: Alan Levine via Flickr / CC BY

Cross-posted with permission from Devex.com.

The World Health Organization’s first global report on diabetes released this month highlights the disease’s “alarming surge” with rates that have quadrupled in fewer than three decades. The report reminds us that essential diabetes medicines and health technologies, including lifesaving insulin, are available in only one in three of the world’s poorest countries.

Availability of medicines is certainly an important piece of the complex challenge of ensuring that health systems seamlessly integrate prevention, screening, referral, treatment, and adherence. However, choosing the best way to spend limited public health budgets amid competing priorities is equally important.

Printer Friendly Version
Subscribe to RSS - pharmaceutical financing